Emerging mutations at relapse in patients with FLT3-mutated relapsed/refractory acute myeloid leukemia who received gilteritinib therapy in the phase 3 ADMIRAL trial Meeting Abstract
| Authors: | Smith, C. C.; Levis, M. J.; Perl, A. E.; Martinelli, G.; Neubauer, A.; Berman, E.; Montesinos, P.; Baer, M. R.; Larson, R. A.; Chou, W. C.; Yokoyama, H.; Recher, C.; Yoon, S. S.; Hill, J. E.; Rosales, M.; Bahceci, E. |
| Abstract Title: | Emerging mutations at relapse in patients with FLT3-mutated relapsed/refractory acute myeloid leukemia who received gilteritinib therapy in the phase 3 ADMIRAL trial |
| Meeting Title: | 61st Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 134 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Dec 7-10 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2019-11-13 |
| Start Page: | 14 |
| Language: | English |
| ACCESSION: | WOS:000518218500409 |
| DOI: | 10.1182/blood-2019-122620 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 613 -- Source: Wos |
